ADAR1 Capital Management »

Immunic shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 30k 0.00

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Immunic

Standard Life Aberdeen
BVF
Avidity Partners Management
Vanguard Capital Management
Vanguard Group
Soleus Capital Management
Laurion Capital Management
Millennium Management
Morgan Stanley
Colony
Nantahala Capital Management
683 Capital Management
Propel Bio Management
Geode Capital Management
Adage Capital Partners GP

View all funds holding Immunic